It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2010.
2010 | Hyderabad, Telangana, India | Struck OffGlanis Life Sciences Private Limited, a struck off private limited company, was established on 31 May 2010 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232TG2010PTC068681. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹0.10 M.
Formerly known as Janani Labs Private Limited. It upholds a compliant status. Its leadership includes Sri Lakshmi Kondru (Director), Sridhar Vootla (Director), Kudaravalli Sridhar (Director). Past directors included Sri Lakshmi Kondru, Vemuri Sambasiva Rao, Sridhar Vootla. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Plot No. 406A, H. No. 622 Road No. 18, Jubilee Hills, Hyderabad, Telangana, 500033.
U24232TG2010PTC068681
068681
31 May 2010
₹5.00 Cr
₹0.10 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Glanis Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sri Lakshmi Kondru | Director | 28 Sep 2012 | Current |
| Sridhar Vootla | Director | 16 Jan 2013 | Current |
| Kudaravalli Sridhar | Director | 16 Jan 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 18 Jan 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 18 Jan 2013 | Past |
| Pramod Abcsdd | Director | 18 Jan 2013 | Past |
| Pramod Abcsdd | Additional Director | 18 Jan 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glanis Life Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 7.1% increase in profit. The company's net worth dipped by a decrease of 1.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Glanis Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Glanis Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Glanis Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glanis Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Glanis Life Sciences Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.
Progress on Glanis Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was documented.
The activity Sridhar Vootla was appointed as a Director was appointed as a Director on 16 Jan 2013 & has been associated with this company since 13 years 1 day . was completed.
Progress on Kudaravalli Sridhar was appointed as a Director was appointed as a Director on 16 Jan 2013 & has been associated with this company since 13 years 1 day . was documented.
Sri Lakshmi Kondru was appointed as a Director was appointed as a Director on 28 Sep 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.
Glanis Life Sciences Private Limited was registered on 31 May 2010 with Roc Hyderabad & aged 15 years 7 months as per MCA records. was recorded as a recent event.
The CIN of Glanis Life Sciences Private Limited is U24232TG2010PTC068681.
Glanis Life Sciences Private Limited is headquartered at Plot No. 406A, H. No. 622 Road No. 18, Jubilee Hills, Hyderabad, Telangana, 500033.
Glanis Life Sciences Private Limited was incorporated on 31 May 2010.
The current directors of Glanis Life Sciences Private Limited are
The primary industry of Glanis Life Sciences Private Limited is Pharma.
Glanis Life Sciences Private Limited is unlisted.
The authorized capital of Glanis Life Sciences Private Limited is ₹5.00 Cr, and the paid-up capital is ₹0.10 M.
The compliance status of Glanis Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX